Kuvatris Therapeutics, Inc. financial data

Location
Tarrytown, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2024 - 14 Jan 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 139% % -13%
Debt-to-equity 1119% % 346%
Return On Equity -6454% % -301%
Return On Assets -529% % -15%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 126,264,370 shares
Common Stock, Shares, Outstanding 10,879,170 shares 913%
Weighted Average Number of Shares Outstanding, Basic 9,056,259 shares 832%
Weighted Average Number of Shares Outstanding, Diluted 9,056,259 shares 832%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $3,184,013 USD 6.6%
General and Administrative Expense $8,778,731 USD -36%
Operating Income (Loss) $11,962,744 USD 29%
Nonoperating Income (Expense) $1,525,335 USD -79%
Net Income (Loss) Attributable to Parent $13,488,079 USD 23%
Earnings Per Share, Basic 2.42 USD/shares 98%
Earnings Per Share, Diluted 2.42 USD/shares 98%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current $820,380 USD -75%
Assets $820,380 USD -75%
Accounts Payable, Current $2,145,739 USD
Liabilities, Current $2,251,950 USD -31%
Liabilities $2,751,950 USD -27%
Retained Earnings (Accumulated Deficit) $59,597,347 USD -29%
Stockholders' Equity Attributable to Parent $1,931,570 USD -260%
Liabilities and Equity $820,380 USD -75%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,068,471 USD -2.9%
Net Cash Provided by (Used in) Financing Activities $15,279 USD -100%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 10,879,170 shares 913%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $444,855 USD -61%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $57,664,684 USD 27%
Share-based Payment Arrangement, Expense $1,513,399 USD -30%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%